What Is Prior Authorization for Injury Medications?

James Wong — Founder & Pharmacist, LienScripts | April 22, 2024 | 6 min read

Prior authorization is an insurance requirement that forces patients to get pre-approval before filling certain prescriptions. For personal injury patients, it creates treatment-ending delays — but pharmacy liens bypass the entire process.

This post is for informational purposes only and does not constitute legal advice.

What Is Prior Authorization?

Prior authorization (PA) — sometimes called pre-authorization or pre-approval — is a requirement imposed by health insurers that certain medications or procedures must be approved by the insurer before the patient can access them. The provider submits documentation justifying medical necessity, the insurer reviews it, and then either approves or denies coverage.

In routine healthcare, prior authorization is an inconvenience. In personal injury cases, it can be a case-altering barrier.

[!KEY] Prior authorization is an insurance gatekeeping requirement that forces pre-approval before a medication can be dispensed — a pharmacy lien bypasses it entirely because no insurance is billed and the prescribing physician's order is the only approval needed.

Why PI Patients Run Into Prior Authorization Problems

Personal injury patients face a unique combination of circumstances that makes prior authorization especially problematic.

High-cost medications are more common. PI injuries often require specialty medications that insurers flag for PA — CGRP inhibitors for post-traumatic migraines, extended-release opioids for severe pain, compound topical preparations for localized injury pain. These are exactly the medications most likely to require pre-authorization.

Injury diagnoses may not match insurer guidelines. PA criteria are built around chronic disease management. A traumatic injury — whiplash, herniated disc, nerve damage from an accident — may not fit neatly into the insurer's approved diagnosis pathways, triggering denial even when the medication is medically appropriate.

Prescribers are often outside the patient's network. After an accident, patients frequently see new specialists — orthopedists, neurologists, pain management physicians — who may not be familiar with the patient's insurer's PA requirements. Denials based on administrative deficiencies are common.

Cases take time. A PA approval for a three-month supply doesn't automatically renew. As cases drag on, patients may need repeated PA approvals while their treatment continues. Each renewal is another opportunity for denial.

How Pharmacy Liens Bypass Prior Authorization

This is one of the most significant practical advantages of a pharmacy lien: no prior authorization required.

A pharmacy lien — like those administered by LienScripts — is a private arrangement between the pharmacy and the patient that operates entirely outside the insurance system. There is no insurance company involved in the dispensing decision. The pharmacy dispenses based on a valid prescription from a licensed physician. Period.

There is no PA process, no formulary check, no network requirement, and no approval to wait for. A patient enrolled in a pharmacy lien program can fill a prescription for a CGRP inhibitor, a compound pain cream, or a specialty non-formulary medication the same day it is prescribed — regardless of what their health insurance would have required.

This matters most for patients whose injuries require medications that would be difficult or impossible to get approved under their health plan. For a deeper look at specialty and non-formulary medications in PI cases, see our posts on specialty medications in personal injury and compound medications for PI patients.

[!NOTE] If your injury medication is denied or delayed by prior authorization, a pharmacy lien through LienScripts can fill it the same day it is prescribed — no insurance company involvement, no waiting period.

Formulary vs. Non-Formulary: The PA Trigger

[!KEY] Many of the most clinically appropriate PI medications — CGRP inhibitors, specialty topicals, compound preparations — are non-formulary or require prior authorization under standard health plans, making the pharmacy lien's freedom from formulary restrictions especially valuable for patients with complex injury-related prescribing needs.

Health insurance formularies are tiered lists of approved drugs. Medications on the formulary at lower tiers are covered without PA. Medications on higher tiers — or off-formulary entirely — typically require prior authorization before the insurer will pay.

Many of the most clinically appropriate medications for PI injuries are non-formulary or on high tiers:

• CGRP inhibitors (Qulipta, Nurtec, Aimovig, Emgality) for post-traumatic migraine — typically require PA even on plans that cover them.
• Specialty topicals (Qutenza, Flector patches, Ztlido) — often non-formulary or require PA.
• Buprenorphine-based pain management — high scrutiny and PA requirements at most insurers.
• Compound preparations — almost universally non-formulary; insurers rarely cover them at all.

Under a pharmacy lien, the formulary is irrelevant. See our overview of CGRP medications for post-traumatic migraine and our guide to prior authorization workarounds in PI cases for additional context.

What to Do If Your Prescription Is Denied

If a patient's insurance denies a medication and a pharmacy lien is available, the path is straightforward: enroll the patient in the lien program and fill the prescription without insurance involvement.

If the denial happens before a pharmacy lien is in place, the options are:

Appeal the denial. Most health plans have a formal appeals process. The treating physician can submit a peer-to-peer review request to challenge the denial. This takes time but can succeed for medically well-documented cases.

Request an exception. Some plans allow exceptions to formulary or PA requirements for specific diagnoses. A strong letter of medical necessity from the treating physician supporting the injury causation can sometimes succeed.

Enroll in a pharmacy lien. If the appeals process is too slow or is unlikely to succeed, enrolling in a pharmacy lien is often the fastest solution. LienScripts can typically begin processing a new enrollment quickly. Contact LienScripts to learn about enrollment for your client.

The LienScripts Approach to PA Barriers

LienScripts works directly with prescribers and attorneys to ensure enrolled patients can access all clinically appropriate medications without insurance-imposed barriers. When a prescribing physician recommends a medication that would ordinarily require prior authorization, the LienScripts pharmacy lien program removes that barrier entirely.

This is particularly valuable for patients with complex injuries who require multiple specialty medications — exactly the patients whose treatment is most vulnerable to insurance interference. For more on how the pharmacy lien enrollment process works, see our post on how to enroll in a pharmacy lien.

Key Takeaway

[!KEY] When a prior authorization denial delays or prevents treatment, document the denial in writing immediately — a dated denial letter establishes that the patient needed the medication, the system responsible for their care refused it, and the pharmacy lien was the only available access mechanism, all of which strengthens the damages narrative.

Prior authorization is an insurance gatekeeping mechanism that delays and denies access to medications PI patients need. A pharmacy lien bypasses prior authorization entirely because the medication is dispensed outside the insurance system. For patients whose injury medications would be subject to PA delays or denials, a pharmacy lien is often the most reliable path to consistent, uninterrupted treatment.